Treatment Options for HER2+ Breast Cancer Are Now Differentiated by Genomic Assay.

Published Date: 20 May 2023

A group of Spanish oncologists changed treatment plans for 56 percent of 89 patients with HER2-positive (HER2+) early breast cancer as a result of the prognostic genomic assay's findings.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Researchers find distinct cell receptors with the potential for new treatments.

2.

Breast cancer patients' arms swell less after an effective lymph node transfer.

3.

Telehealth in the pandemic era resulted in fewer therapy interruptions.

4.

Too Many Chest CTs for Incidental Lung Nodules?

5.

Global warming could be driving up women's cancer risk, find researchers


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot